Herpes zoster panuveitis progression despite acyclovir treatment in a patient following bone marrow transplantation.
Fujiwara
Osamutaro
O
Department of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo, Japan. fujiwara@sapmed.ac.jp.
Mitamura
Yoshinori
Y
Department of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
Ohtsuka
Kenji
K
Department of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006563:Herpes Zoster Ophthalmicus / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014645:Herpesvirus 3, Human / Q000235:genetics / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery; D015864:Panuveitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D000914:Antibodies, Viral; D004279:DNA, Viral; D007074:Immunoglobulin G; D000212:Acyclovir